Skip to main content

Table 2 Health screening measurements, source of population norm data, compliance with population norms, and age and gender effects on non-compliance. An OR less than 1 indicates that males are more likely than females to have the outcome and an OR greater than 1 indicates that females are more likely to have the outcome than males

From: Health deficits in community dwelling adults aged 40 to 75 years

Measure

Non-compliant

n (%)

Independent age group effect

Independent gender effect

Age and gender subgroups

(OR 95% CI)

(OR 95% CI)

(OR 95% CI)

Comparator 40–49 y

Comparator Female

Comparator Female 40-49y

Overweight or obese*

338 (61.1)

40-49y OR = 1

0.7 (0.5–1.0)

 

BMI 25–29.9 (overweight), 30+ (obese) [13]

50-59y 1.7 (1.1–2.9)

60-69y 1.8 (1.2–2.9)

70 + y 2.2 (1.3–3.9)

Waist-hip ratio

298 (53.1)

40-49y OR = 1

0.2 (0.1–0.3)

Compared with F 40-49y:

 

50-59y 0.5 (0.3–0.7)

M40-49y 0.2 (0.07–0.4)

High risk: >  0.90 for males; >  0.85 for females [13]

60-69y 1.0 (0.6–1.7)

M50-59y 0.3 (0.1–0.5)

70 + y 1.1 (0.7–3.9)

M60-69y 0.6 (0.3–0.3)

Physical activity* (see Footnote for description)

293 (52.9)

No significant age effects

1.5 (1.1–2.1)

 

Blood Glucose 3.0–7.7 mmol/L [16]

216 (38.5)

No significant age effects

No significant gender effects

 

Audiology*

188 (33.9)

40-49y OR = 1

0.6 (0.4–0.9)

Compared with F40-49y:

7 or 8 = pass [17]

50-59y 2.5 (1.2–5.0)

F 50-59y 3.1 (1.2–8.1)

 

60-69y 7.6 (3.9–14.6)

F 60-69y 6.0 (2.4–15.1)

70 + y 6.7 (3.4–13.3)

F 70 + y 7.3 (2.9–18.6)

M 60-69y 20.0 (7.3–54.5)

    

M 70 + y 8.4 (2.8–24.9)

Waist circumference*

185 (33.4)

No significant age effects

2.1 (1.4–3.2)

Compared with F 40-49y:

High risk: females: ≥ 88 cm

M 40-49y 0.04 (0.01–0.1)

males: ≥102 cm or more [13]

M 50-59y 0.1 (0.05–0.3)

M 60-69y 0.14 (0.1–0.3)

M70 + y 0.1 (0.05–0.2)

Cognition and memory*

179 (32.3)

No significant age effects

No significant gender effects

 

GPCog <=8 [18]

Blood pressure*

164 (29.6)

40-49y OR = 1

No significant gender effects

Compared with F 40-49y:

90-140 mmHg systolic, 60-90 mmHg diastolic [16]

50-59y 1.3 (0.7–2.3)

 

F 70 + y 2.5 (1.2–5.3)

60-69y 1.5 (0.9–2.5)

M 60-69y 2.7 (1.2–6.1)

70 + y 1.9 (1.1–3.5)

Mobility*

140 (25.3)

40-49y OR = 1

1.4 (1.0–2.2)

Compared with F 40-49y:

Six Minute Walk Test (6MWT)

50-59y 1.3 (0.8–3.1)

F 70 + y 4.1 (1.8–8.9)

6MWDm = 518.853 + (1.25 x height in cm) – (2.816 x age in years) – (39.07 x sex men = 0; women = 1) [19, 20]

60-69y 2.3 (1.2–4.3)

70 + y 3.8 (1.9–7.4)

Foot sensation*

123 (22.6)

40-49y OR = 1

0.6 (0.4–0.9)

Compared with F 40-49y:

Mono-filament testing All 20 correct responses (10 each foot) [21

50-59y 2.2 (1.0–4.5)

F 60-69y 3.6 (1.3–9.9)

60-69y 2.9 (1.5–5.9)

F 70 + y 4.2 (1.5–11.6)

70 + y 4.1 (2.0–8.5)

M 50-59y 4.0 (1.6–12.8)

M 60-69y 4.8 (1.6–14.1)

M 70 + y 10.2 (3.2–32.4)

Perceived exertion*

115 (20.5)

No significant age effects

No significant gender effects

 

Borg Exertion Scale

scale 6–20, at-risk values> 13 [22]

Sleep quality*

113 (20.4)

No significant age effects

No significant gender effects

 

Pittsburgh Sleep Quality Index)(PSQI) ≥ 8 [23, 24]

Lung capacity*

82 (14.8)

No significant age effects

No significant gender effects

Compared with F 40-49y)

FEV1, FVC Normative tables for age and gender see [25]

M 40-49y 3.9 (1.3–11.9)

M 50-59y 3.9 (1.2–12.3)

Dexterity*

82 (14.4)

No significant age effects

No significant gender effects

 

The Purdue Dexterity Test norms see [26]

Grip strength* (dominant hand) Hand held dynamometer

74 (13.4)

No significant age effects

No significant gender effects

 

At-risk is in lowest 20th% of gender-age distribution [27, 28]

Respiratory rate*

17 (13.1)

No significant age effects

No significant gender effects

 

12–20 breaths/min [16]

Oximetry*

36 (6.5)

40-49y OR = 1

No significant gender effects

 

< 96% [16]

50-59y 6.1 (0.73–50.3)

 

60-69y 1.8 (1.5–90.4)

70 + y 9.7 (1.2–77.3)

K10 Psychological Distress*

32 (5.8)

No significant age effects

No significant gender effects

 

≥ 13 [29]

Dyspnoea

8 (1.4)

No significant age effects

No significant gender effects

 

Borg Dyspnoea Scale At-risk values > 4 [22]

Temperature

3 (0.5)

No significant age effects

No significant gender effects

 

35.5–37.5 degrees C [16]

Heart rate

4 (0.4)

No significant age effects

No significant gender effects

 

60–100 beats per min [16]

  1. Key: Significant differences between expected compliance and percentage of non-compliant scores (p < 0.05) identified by* after each measure; significant age group effects identified by italics: CI confidence interval, F female, M male, OR odds ratio, y years
  2. Footnote: Active Australia Survey 18–65 year olds at risk: < 150 to 300 min (2 ½ to 5 h) moderate intensity physical activity, or 75 to 150 min (1 ¼ to 2 ½ hours) of vigorous intensity physical activity, or combination of both, each week. 65+ years at-risk: < 30 min moderate intensity physical activity on most days [14, 15]